Abstract
Background
Oral manifestations of chronic graft-vs.-host disease (cGVHD) can significantly affect the quality of life and severity often does not correlate with systemic manifestations. We evaluated the use of topical corticosteroids and the intraoral application of psoralen-UVA (PUVA) for treatment of oral manifestations of cGVHD.Methods
Overall, 18 patients with oral manifestations of cGVHD were treated with either intraoral PUVA (n=7) or with topical corticosteroids (n=16). Four patients received intraoral PUVA after failure of topical steroids and one patient was treated with topical corticosteroids after failing treatment with intraoral PUVA. A glass fiber extension of an UVA source was used for manual intraoral application. Treatment with topical corticosteroids consisted of 0.1 mg/ml dexamethasone mouth wash four times a day in combination with antifungal prophylaxis.Results
Four patients showed complete local response (CR) due to intraoral PUVA, two improved and one did not respond. Topical corticosteroids resulted in nine patients in CR, two improved and five did not respond.Conclusion
Intraoral PUVA as well as topical corticosteroids are effective in treatment of oral manifestations of oral GVHD with few side-effects and improve quality of life in patients with cGVHD.References
Articles referenced by this article (39)
Development of a prognostic model for grading chronic graft-versus-host disease.
Blood, (5):1219-1226 2001
MED: 11222363
The significance of oral mucosal and salivary gland pathology after allogeneic bone marrow transplantation.
Arch Dermatol, (8):964-965 1995
MED: 7632078
Major salivary gland involvement in graft-versus-host disease: considerations related to pathogenesis, the role of cytokines and therapy.
Cytokines Cell Mol Ther, (4):227-232 1999
MED: 10850387
Weight loss and malnutrition in patients with chronic graft-versus-host disease.
Bone Marrow Transplant, (3):231-236 2002
MED: 11859395
Topical cyclosporine in a bioadhesive for treatment of oral lichenoid mucosal reactions: an open label clinical trial.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod, (5):532-536 1996
MED: 8936517
Topical azathioprine in the combined treatment of chronic oral graft-versus-host disease.
Bone Marrow Transplant, (6):683-687 2000
MED: 10734307
Pilocarpine hydrochloride for symptomatic relief of xerostomia due to chronic graft-versus-host disease or total-body irradiation after bone-marrow transplantation for hematologic malignancies.
Leuk Lymphoma, (5-6):539-543 1997
MED: 9086444
Title not supplied
Photodermatology 1987
Intraoral psoralen ultraviolet A irradiation (PUVA) treatment of refractory oral chronic graft-versus-host disease following allogeneic stem cell transplantation.
Bone Marrow Transplant, (8):807-808 2001
MED: 11781637
[Initial results of the long-term effect of PUVA therapy in lichen ruber of the mouth].
Dermatol Monatsschr, (5-6):349-355 1990
MED: 2227053
Show 10 more references (10 of 39)
Citations & impact
Impact metrics
Citations of article over time
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1111/j.1600-0781.2004.00102.x
Article citations
Oral Chronic Graft-Versus-Host Disease: Pathogenesis, Diagnosis, Current Treatment, and Emerging Therapies.
Int J Mol Sci, 25(19):10411, 27 Sep 2024
Cited by: 0 articles | PMID: 39408739 | PMCID: PMC11476840
Review Free full text in Europe PMC
Treatment of oral graft-versus-host disease with intraoral nbUVB phototherapy.
Support Care Cancer, 32(7):438, 17 Jun 2024
Cited by: 0 articles | PMID: 38880860
Oral Manifestations of Graft vs. Host Disease: A Comprehensive Review for Best Practice in Dentistry.
Medicina (Kaunas), 59(11):1937, 01 Nov 2023
Cited by: 1 article | PMID: 38003987
Review
Topical treatment of oral chronic graft-versus-host- disease in hematopoietic stem cell transplant recipients: A systematic review.
J Clin Exp Dent, 15(5):e420-e427, 01 May 2023
Cited by: 0 articles | PMID: 37214749 | PMCID: PMC10198688
Review Free full text in Europe PMC
Perspectives on oral chronic graft-versus-host disease from immunobiology to morbid diagnoses.
Front Immunol, 14:1151493, 28 Jun 2023
Cited by: 1 article | PMID: 37449200 | PMCID: PMC10338056
Review Free full text in Europe PMC
Go to all (33) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA).
Bone Marrow Transplant, 17(6):1061-1067, 01 Jun 1996
Cited by: 74 articles | PMID: 8807115
PUVA therapy for chronic cutaneous graft-vs-host disease.
Arch Dermatol, 127(11):1673-1678, 01 Nov 1991
Cited by: 40 articles | PMID: 1952971
The effect of budesonide mouthwash on oral chronic graft versus host disease.
Am J Hematol, 82(5):349-356, 01 May 2007
Cited by: 27 articles | PMID: 17109390
Chronic graft versus host disease of oral mucosa: review of available therapies.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 101(2):175-183, 01 Feb 2006
Cited by: 40 articles | PMID: 16448918
Review